Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Endo International plc
Index- P/E- EPS (ttm)-9.08 Insider Own0.40% Shs Outstand153.67M Perf Week5.55%
Market Cap9.99B Forward P/E14.65 EPS next Y4.44 Insider Trans8.66% Shs Float149.78M Perf Month-4.87%
Income-1003.90M PEG- EPS next Q0.98 Inst Own97.20% Short Float6.62% Perf Quarter-2.88%
Sales2.46B P/S4.07 EPS this Y21.20% Inst Trans-0.04% Short Ratio4.64 Perf Half Y7.40%
Book/sh18.43 P/B3.53 EPS next Y9.01% ROA-14.20% Target Price76.42 Perf Year42.73%
Cash/sh9.59 P/C6.78 EPS next 5Y5.16% ROE-60.80% 52W Range43.12 - 82.16 Perf YTD-3.59%
Dividend- P/FCF403.01 EPS past 5Y-33.80% ROI-8.50% 52W High-20.84% Beta1.17
Dividend %- Quick Ratio1.30 Sales past 5Y15.70% Gross Margin57.60% 52W Low50.83% ATR2.32
Employees3371 Current Ratio1.50 Sales Q/Q0.90% Oper. Margin22.50% RSI (14)50.77 Volatility3.08% 3.73%
OptionableYes Debt/Eq1.57 EPS Q/Q-37.50% Profit Margin-46.90% Rel Volume0.62 Prev Close64.66
ShortableYes LT Debt/Eq1.51 EarningsNov 03 Payout- Avg Volume2.13M Price65.04
Recom2.10 SMA20-0.81% SMA50-0.11% SMA200-3.80% Volume1,324,463 Change0.59%
02-Sep-14Initiated RBC Capital Mkts Outperform $80
01-Aug-14Reiterated Stifel Buy $75 → $84
27-Jun-14Initiated Canaccord Genuity Buy $83
30-Apr-14Initiated National Alliance Securities Buy $76
04-Mar-14Reiterated FBR Capital Mkt Perform $52 → $82
03-Mar-14Reiterated UBS Buy $75 → $90
06-Nov-13Upgrade Needham Underperform → Hold
06-Nov-13Reiterated Stifel Buy $40 → $60
30-Oct-13Initiated FBR Capital Mkt Perform $40
20-Sep-13Reiterated UBS Buy $43 → $50
21-Jun-13Resumed Oppenheimer Perform
06-Jun-13Reiterated UBS Buy $39 → $41
06-Jun-13Reiterated Stifel Buy $36 → $40
06-Jun-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
13-May-13Reiterated Stifel Buy $42 → $36
08-May-13Reiterated RBC Capital Mkts Underperform $28 → $29
17-Apr-13Reiterated Stifel Buy $38 → $42
10-Apr-13Downgrade Standpoint Research Buy → Hold
31-Jan-13Reiterated Cantor Fitzgerald Hold $26 → $34
31-Jan-13Downgrade Oppenheimer Outperform → Perform
20-Oct-14 04:00PM  Endo to Announce Third Quarter 2014 Financial Results on November 5, 2014 PR Newswire
14-Oct-14 03:51PM  Sterne Agee Sees Entry Point In Endo International PLC Shares Benzinga
12:01AM  [$$] BioDelivery Sciences May Deliver Less at Barrons.com
13-Oct-14 10:33PM  AUXILIUM PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Auxilium Pharmaceuticals, Inc. PR Newswire
12:42PM  How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action? at TheStreet
08:00AM  Top Analyst Upgrades and Downgrades: Cliffs, CME, Darden, Endo, J.C. Penney and More at 24/7 Wall St.
10-Oct-14 05:37PM  Inversion Vitriol Vs. Drug Consolidation Investor's Business Daily
04:45PM  Endo to Buy Auxilium for $2.6B, Diversify Portfolio Zacks
02:56PM  UPDATE: Mizuho Securities Downgrades Auxilium Pharmaceuticals Benzinga
06:47AM  The Morning Ledger: Early Inversion Deal Makers Come Back for More at The Wall Street Journal
09-Oct-14 11:58PM  [$$] Tax-Inversion Players Swoop In for Seconds at The Wall Street Journal -5.94%
07:00PM  Endo Buyout Of Auxilium Joins Two Changing Firms at Investor's Business Daily
05:23PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem EDGAR Online
04:55PM  Dow Suffers Worst One-Day Performance In 2014, Volatility Returns To The Markets Benzinga
02:54PM  Endo bolsters men's healthcare business with Auxilium deal Reuters
01:53PM  How Endo International's $2.6B Deal for Auxilium Benefits Shareholders at TheStreet
09:42AM  [$$] Endo International to Buy Auxilium at The Wall Street Journal
09:32AM  [video] Endo buys Auxilium Pharma at CNBC
09:19AM  Morning Movers: Gap Tumbles on CEO Retirement; Pepsi Pops on Earnings at Barrons.com
09:10AM  Stock Futures Down, Off Lows; Alcoa, United, Auxilium Rise at Investor's Business Daily
08:37AM  Endo Intl to buy Auxilium in deal worth $2.6B AP
08:15AM  US STOCKS-Futures turn lower as global growth concerns weigh Reuters
07:56AM  US STOCKS-Results boost Alcoa, PepsiCo in premarket trading Reuters
07:41AM  Early Movers: PEP, AUXL, ENDP, HLT, MW, RT & more at CNBC
07:02AM  Endo Reaches Deal to Buy Auxilium Pharmaceuticals for $2.6B at TheStreet
06:53AM  Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal Reuters
06:48AM  Endo Agrees to Buy Auxilium for $2.6 Billion at Bloomberg
06:30AM  Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion PR Newswire
06-Oct-14 05:15PM  Mylan Surges on Improved Q3 and Full-Year Earnings Outlook Zacks
03-Oct-14 07:58PM  Endo Accused of Conspiring to Delay Generic Version of Opana at Bloomberg
12:11PM  Damages slashed to $34.6 mln in Boston Scientific mesh trial Reuters
02-Oct-14 04:00PM  AbbVie's (ABBV) Humira Gains Yet Another FDA Approval Zacks
01-Oct-14 05:16PM  Endo Finance Co. -- Endo's new mesh litigation accrual is credit negative at Moody's
12:01AM  Endo Said to Pay $400 Million Plus in Vaginal-Mesh Accord at Bloomberg
30-Sep-14 07:35PM  Endo reaches deal to end remaining U.S. lawsuits over mesh Reuters
05:18PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:08PM  Endo Reaches Master Settlement Agreements to Resolve Substantially All Remaining AMS Mesh Litigation Claims PR Newswire
29-Sep-14 04:25PM  Endocyte's TARGET Interim Data Positive for Lung Cancer Zacks
04:20PM  Gilead's HCV Combo Drug Harvoni Secures CHMP Backing Zacks
07:53AM  Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher Zacks
06:50AM  Karyopharm Therapeutics, Inc. (KPTI) Surges: Stock Adds 10.5% Zacks
06:40AM  Cempra (CEMP) Jumps: Stock Up 8.9% in Session Zacks
06:35AM  Cerulean Pharma (CERU) Jumps: Stock Up 9.8% in Session Zacks
26-Sep-14 04:10PM  Alnylam Starts New Study on Cardiac Amyloidosis Patients Zacks
07:31AM  IGI, Laboratories (IG) Jumps: Stock Up 18.1% in Session Zacks
25-Sep-14 05:24PM  BioMarin (BMRN) Faces Threat of Genericization for Kuvan Zacks
04:20PM  Gilead Scores with TAF-based HIV Regimen, Shares Up Zacks
08:00AM  Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% Zacks
07:54AM  Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% Zacks
07:31AM  The Zacks Analyst Blog Highlights: Auxilium Pharmaceuticals, QLT, Endo International, Gilead and Regeneron Zacks
24-Sep-14 04:45PM  Galmed's Aramchol Gets Fast-Track Designation in the U.S. Zacks
04:20PM  Emergent BioSolutions Initiates Pivotal Study on BioThrax Zacks
10:06AM  Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA Zacks
07:46AM  ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher Zacks
07:06AM  Salix Pharmaceuticals (SLXP) in Focus: Stock Up 5.8% Zacks
06:39AM  Radius Health (RDUS) in Focus: Stock Surges 17.3% Zacks
23-Sep-14 03:55PM  Supernus Confirms 2014 Outlook, Epilepsy Products in Focus Zacks
02:45PM  Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid Zacks
22-Sep-14 04:38PM  Auxilium Says Endo Takeover Offer Undervalues Company at Investor's Business Daily
11:20AM  Auxilium says Endo offer undervalues company, but open to talks Reuters
10:27AM  Endo: Buyout offer for Auxilium 'compelling,' provides 'substantial premium' at MarketWatch
09:40AM  4 Stocks Spiking on Big Volume at TheStreet
09:38AM  Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal PR Newswire
07:45AM  Auxilium Pharma rejects Endo's takeover offer AP
07:25AM  Auxilium says Endo's offer "significantly undervalues" company Reuters
19-Sep-14 04:15PM  Spectrum Pharmaceuticals Out-Licenses Products in China Zacks
04:10PM  Bayer to Shed MaterialScience Business, Shares Rise Zacks
08:44AM  Zacks Rank #1 Additions for Friday Zacks
06:59AM  Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Zacks
18-Sep-14 04:11PM  OncoGenex's Phase III Prostate Cancer Study Fully Enrolled Zacks
08:10AM  Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher Zacks
17-Sep-14 06:07PM  Auxilium Mulls Endo Bid; Is $2.2 Billion Enough? at Investor's Business Daily
05:39PM  [$$] Auxilium Is Buyable, but Requires Higher Bid at Barrons.com
03:50PM  Endo Looking to Acquire Auxilium Pharmaceuticals for $2.2B Zacks
11:47AM  Auxilium Mulls Endo Bid; Street Eyes A Higher Price at Investor's Business Daily
11:33AM  Endo & Auxilium: When $2.2 Billion is Not Enough at Barrons.com
11:14AM  Markets Gain; FedEx Profit Beats Street View Benzinga
10:05AM  Why Endo Wants to Acquire Auxilium So Much at 24/7 Wall St.
10:02AM  Auxilium Pharmaceuticals, Inc. -- Moody's reviews Auxilium's ratings for upgrade at Moody's
09:38AM  Endo Finance Co. -- Moody's reviews Endo's ratings for downgrade at Moody's
09:33AM  Why Auxilium Pharmaceuticals (AUXL) Stock Is Spiking Today at TheStreet
09:02AM  Morning Movers: FedEx Flies on Earnings Beat; Auxilium Jumps on Endo Bid at Barrons.com
08:02AM  Auxilium confirms unsolicited Endo bid at MarketWatch
07:48AM  [$$] Auxilium Confirms Endo Bid at The Wall Street Journal
07:23AM  Auxilium Pharma adopts poison pill after Endo's unsolicited bid Reuters
07:00AM  Auxilium Responds To Unsolicited Proposal From Endo International PR Newswire
16-Sep-14 10:01PM  Endo's $2.2 bln offer could complicate Auxilium Pharma's QLT deal Reuters
06:25PM  [$$] Endo Offers to Acquire Auxilium for $2.2 Billion at The Wall Street Journal
05:53PM  Endo Int'l makes $1.4B offer for Auxilium Pharma AP
05:42PM  Auxilium Pharmaceuticals, Inc. Gets $2.2 Billion Unsolicited Bid Benzinga
05:33PM  Biotech Company Auxilium Explodes After Takeover Offer Business Insider
05:23PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:17PM  Why Endo International (ENDP) Stock Is Up in After-Hours Trading Today at TheStreet
05:01PM  Endo offers to buy Auxilium Pharma for about $2.2 bln Reuters
04:53PM  Endo Bids $2.2 Billion for Mens Health Drugmaker Auxilium at Bloomberg
04:45PM  Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock PR Newswire
03:45PM  Gilead (GILD) Slips on Generic Sovaldi Licensing Deals Zacks
06:05AM  PTC Therapeutics (PTCT) Soars: Stock Adds 11.5% is Session Zacks
11-Sep-14 08:22AM  Strength Seen in Flexion Therapeutics (FLXN): Stock Soars 17.8% Zacks
10-Sep-14 07:57AM  Endocyte (ECYT) Worth Watching: Stock Soars 17% Zacks
Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men's and women's health, and prostate health. The company's products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.